Night Owl Capital Management LLC Has $43.99 Million Position in UnitedHealth Group Incorporated $UNH

by · The Cerbat Gem

Night Owl Capital Management LLC increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 39.3% in the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 83,996 shares of the healthcare conglomerate’s stock after purchasing an additional 23,694 shares during the period. UnitedHealth Group makes up 5.5% of Night Owl Capital Management LLC’s investment portfolio, making the stock its 7th largest holding. Night Owl Capital Management LLC’s holdings in UnitedHealth Group were worth $43,993,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently bought and sold shares of UNH. Bayforest Capital Ltd boosted its position in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after purchasing an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd boosted its position in shares of UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after buying an additional 50 shares during the period. IAG Wealth Partners LLC bought a new stake in shares of UnitedHealth Group during the 1st quarter worth approximately $42,000. Copia Wealth Management purchased a new stake in UnitedHealth Group in the fourth quarter worth $42,000. Finally, O Brien Wealth Partners LLC grew its holdings in shares of UnitedHealth Group by 74.0% in the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate’s stock worth $46,000 after purchasing an additional 37 shares during the last quarter. 87.86% of the stock is owned by institutional investors.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the company’s stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares in the company, valued at approximately $3,171,390. This represents a 5.36% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.28% of the company’s stock.

Analyst Ratings Changes

Several research firms have issued reports on UNH. Oppenheimer lowered their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research report on Wednesday, July 30th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Wells Fargo & Company decreased their target price on UnitedHealth Group from $306.00 to $267.00 and set an “overweight” rating for the company in a research report on Monday, August 4th. Mizuho decreased their price objective on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Finally, Robert W. Baird reiterated an “underperform” rating and set a $198.00 target price (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Fifteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have issued a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $353.71.

View Our Latest Stock Report on UnitedHealth Group

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $309.98 on Friday. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The company has a market cap of $280.74 billion, a PE ratio of 13.43, a P/E/G ratio of 1.99 and a beta of 0.45. The business has a 50-day simple moving average of $288.66 and a two-hundred day simple moving average of $375.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The company had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the business earned $6.80 earnings per share. The firm’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 38.30%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Recommended Stories